WELCOME
The Center of Genetic Engineering and Biotechnology (CIGB) is pleased to announce the IV International Symposium Cancer 2023 to be held at the Selectum Family Resort Hotel, Varadero, Cuba, from September 15 to 19, 2023.
This four-day event will bring together basic scientists, medicinal chemists, pharmacologists, biotechnologists, clinical investigators, and other allied professionals from around the world, interested in the fields of cancer pathogenesis and new targeted therapies development. The meeting will be an excellent opportunity to expose the translational nature of modern biomedical and pharmaceutical research. Within the event, we will dedicate special attention to antiangiogenic passive and active immunotherapeutic strategies and also to the combinations emerging in this field, particularly with checkpoint inhibitors.
General Topics
- Cancer Immunotherapy with a focus on angiogenesis and checkpoint inhibitors
- Cancer Targeted Therapy with emphasis on CKII, COMMD1, and Integrins targeting
- Combination with checkpoint inhibitors
- Tumor Microenvironment
Separated sessions will cover each topic
- Preclinical and early-phase clinical development
- Clinical trials phase II-IV design and results
- Soluble and cellular Biomarkers of Response and Prognosis
Details
- Start:
- 15 septiembre 2023
- End:
- 19 septiembre 2023
- Website:
- /event/iv-simposio-internacional-cancer-2023/
- Varadero, Cuba
Venue
Documentation
Organizer
- Email:
- julio.fernandez@cigb.edu.cu Monica Bequet Romero, PhD. Head of the Scientific Committee, Cancer 2025. Pharmaceuticals Department, Biomedical Research, CIGB
- Email:
- monica.bequet@cigb.edu.cu; monbeq@gmail.com Yanelys Morera Díaz, PhD, Senior Scientist, Leader Cancer Immunotherapy
- Email:
- yanelys.morera@cigb.edu.cu Silvio E. Perea, PhD, Senior Scientist, Leader Molecular Oncology
- Email:
- silvio.perea@cigb.edu.cu
Scientific Comittee
Julio Raúl Fernández, PhD, Head of Pharmaceutics Department, Leader Antitumor TherapyInstructions
Abstracts for presentations in Cancer 2023 meeting should send to biomed@cigb.edu.cu before Julio 31, 2023
Abstracts for Oral Presentations
Abstracts for Oral Presentations must be written in English and should not exceed 250 words. Abstracts should be emailed to the organizers like a Short Report as follows:
Arial 11 pt font and single line spacing
Title: 100 characters (not including spaces). Bold
Authors: 110 Characters (not including spaces). Only Last Name, followed by initials, in italics (Perez, C)
Affiliations: Each author should be listed by department, institution, city, and country.
Body: single paragraph no more than 1500 characters long (including spaces). Text alignment should be justified.
Do not include Tables, figures or Graphs.
Email address of the presenting author is required.
Abstracts for Electronic Poster Presentations (Short Reports)
Abstracts for Electronic Poster Presentations must be written in English and should not exceed 250 words. Abstracts should be emailed to the organizers like a Short Report as follows:
Arial 11 pt font and single line spacing.
Title: 100 characters (not including spaces). Bold
Authors: 110 Characters (not including spaces). Only Last Name, followed by initials, in italics (Perez, C)
Affiliations: Each author should be listed by department, institution, city, and country.
Body: single paragraph no more than 1500 characters long (including spaces). Text alignment should be justified.
Do not include Tables, figures or Graphs.
Email address of the presenting author is required.
Estados Unidos de América
Estados Unidos de América
Estados Unidos de América
Estados Unidos de América
Sponsors